Axsome Therapeutics Cash Flow Statement (2021-2026) | AXSM

Cash Flow Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -39.63M-41.44M-44.82M-61.24M-11.24M-67.19M-62.20M-98.65M-68.36M-79.34M-64.60M-74.91M-59.41M-47.93M-47.23M-28.59M-64.54M
Depreciation and Depletion (Quarter) 0.04M0.07M0.07M0.09M0.09M0.10M0.14M0.13M0.13M0.14M0.13M0.13M0.15M0.12M0.12M0.11M0.12M
Share-based Compensation (Quarter) 0.01M0.01M0.01M37.70M12.94M15.92M16.37M18.91M20.19M21.38M21.66M21.99M23.31M24.61M23.10M22.73M23.44M
Gains from Sales and Divestitures (Quarter) 0.01M0.06M0.06M0.07M0.08M0.15M0.17M0.18M0.19M0.21M0.23M0.25M0.27M0.24M0.27M0.30M0.32M0.29M
Gains from Investment Securities (Quarter) 5.09M1.22M0.11M6.54M0.16M0.70M0.90M0.90M0.04M9.16M1.05M0.30M4.36M0.40M0.34M0.36M1.04M0.67M
Non-cash Items (Quarter) 72.20M2.93M90.30M97.70M95.70M160.30M0.26M4.19M0.32M4.79M5.07M160.90M5.37M5.43M5.60M0.55M5.31M0.77M
Cash from Operations (Quarter) -32.65M-33.54M-22.76M-27.56M-5.82M-55.35M-53.55M-30.36M-53.47M-30.11M-18.63M-26.20M-43.38M-32.42M1.05M-18.65M-20.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.28M0.93M1.61M1.61M1.57M1.59M1.61M0.45M1.59M0.26M1.61M5.70M0.67M0.54M0.68M-0.33M1.57M
Depreciation & Amortization (CF) (Quarter) 0.04M0.07M0.07M0.09M0.09M0.10M0.14M0.13M0.13M0.14M0.13M0.13M0.15M0.12M0.12M0.11M0.12M
Change in Working Capital
Change in Receivables (Quarter) 4.13M17.40M7.09M22.62M11.01M16.41M6.62M18.91M3.75M17.91M19.40M37.43M-2.32M27.96M26.60M
Change in Inventory (Quarter) 0.29M1.32M3.62M1.31M-1.66M4.89M0.10M-0.69M-1.29M1.13M0.25M1.78M4.99M3.64M3.11M
Change in Account Payables (Quarter) -0.55M6.84M-6.59M25.76M-2.83M7.19M-13.86M11.58M13.11M7.55M2.91M7.74M13.66M5.97M-37.40M11.31M41.16M
Change in Accured Expenses (Quarter) 1.69M5.49M23.54M13.20M7.14M3.96M13.98M11.36M-8.41M33.49M5.32M25.67M0.82M21.50M54.25M7.17M17.23M
Other Working Capital Changes (Quarter) 0.21M-0.61M
Investing Activities
Capital Expenditures (Quarter) 0.21M0.24M0.07M0.18M0.07M0.13M0.37M0.01M0.10M0.05M0.09M0.03M0.34M0.01M0.06M0.07M0.12M
Cash from Investing Activities (Quarter) -0.21M-53.24M-0.07M-0.18M-0.07M-0.13M-0.37M-0.01M-0.10M-0.05M-0.09M-0.03M-0.34M-0.01M-0.06M-0.07M-0.12M
Financing Activities
Other financing activities (Quarter) 6.49M1.22M12.40M2.05M0.23M0.26M0.33M0.39M0.52M2.73M-2.44M0.10M
Cash from Financing Activities (Quarter) 31.10M75.46M176.95M1.07M51.56M246.08M33.37M-0.00M-1.19M14.38M30.41M14.24M29.27M34.54M21.27M16.39M2.99M
Additional items
Change in Cash (Quarter) -1.76M-11.31M154.13M-26.68M45.67M190.60M-20.55M-30.37M-54.75M-15.78M11.68M-11.99M-14.44M2.11M22.26M-2.34M-17.83M
Free Cash Flow (Quarter) -32.87M-33.78M-22.82M-27.74M-5.89M-55.48M-53.92M-30.37M-53.56M-30.16M-18.72M-26.23M-43.71M-32.44M0.99M-18.72M-20.82M
Net Cash Flow (Quarter) -1.76M-11.31M154.13M-26.68M45.67M190.60M-20.55M-30.37M-54.75M-15.78M11.68M-11.99M-14.44M2.11M22.26M-2.34M-17.83M